SEPN Competitors & Alternatives
Compare Septerna, Inc. Common Stock with similar stocks in the same industry
Biotechnology
SEPN
Main Stock$35.95
Tradestie Score
59
Market Cap
$847.12M
Revenue Growth
120.1%
Analyst Upside
+27.3%
Top Competitors
220 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
EWTX
Edgewise Therapeutics, Inc. Common Stock
|
$34.83
|
$1.63B | - | 56 | Compare |
|
BHVN
Biohaven Ltd.
|
$11.28
|
$1.57B | - | 61 | Compare |
|
VCEL
Vericel Corporation
|
$37.46
|
$1.56B | 89.7 | 61 | Compare |
|
DNTH
Dianthus Therapeutics, Inc. Common Stock
|
$82.07
|
$1.55B | - | 54 | Compare |
|
HRMY
Harmony Biosciences Holdings, Inc. Common Stock
|
$34.46
|
$1.55B | 14.2 | 65 | Compare |
|
PHVS
Pharvaris N.V. Ordinary Shares
|
$30.72
|
$1.55B | - | 64 | Compare |
|
NVAX
Novavax Inc
|
$8.88
|
$1.54B | - | 50 | Compare |
|
AUPH
Aurinia Pharmaceuticals Inc
|
$15.82
|
$1.50B | 7.4 | 62 | Compare |
|
GPCR
Structure Therapeutics Inc. American Depositary Shares
|
$42.93
|
$1.50B | - | 52 | Compare |
|
AMLX
Amylyx Pharmaceuticals, Inc. Common Stock
|
$14.59
|
$1.49B | - | 59 | Compare |
More SEPN Analysis
Data updated: Jun 15, 2026 | Industry: Biotechnology (SIC 2834)
220 stocks in this industry